Senior insider sale
Chief Accounting Officer at KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC — senior position signals high conviction
$309.3K
6.63K shares
What this filing means
MEGNA MICHAEL R plans to sell 6.63K shares of KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC valued at approximately $309.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/9/2026ACC: 0001921094-26-000386
Officer· Chief Accounting Officer
Since Feb 2020
6.63K
Shares to sell
$309.3K
Approx. market value
6.63K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Lapse
Equity Compensation
4/7/2026
2.27KRestricted Stock Lapse
Equity Compensation
4/1/2026
4.36KTotal acquired6.63K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/7/2026 | Restricted Stock Lapse Equity Compensation | 2.27K | — |
4/1/2026 | Restricted Stock Lapse Equity Compensation | 4.36K | — |
| Total | 6.63K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.63K
Market value
$309.3K
4/9/2026
Total
Units
6.63K
Value
$309.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/9/2026 | 6.63K | $309.3K | NASDAQ | Planned |
| Total | 6.63K | $309.3K | ||